84 related articles for article (PubMed ID: 21636258)
21. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction.
Calabria AR; Weidenfeller C; Jones AR; de Vries HE; Shusta EV
J Neurochem; 2006 May; 97(4):922-33. PubMed ID: 16573646
[TBL] [Abstract][Full Text] [Related]
22. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
[TBL] [Abstract][Full Text] [Related]
23. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
24. Functional test of multidrug transporter activity in hippocampal-neocortical brain slices from epileptic patients.
Kovács R; Raue C; Gabriel S; Heinemann U
J Neurosci Methods; 2011 Sep; 200(2):164-72. PubMed ID: 21763346
[TBL] [Abstract][Full Text] [Related]
25. Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier.
Bubik M; Ott M; Mahringer A; Fricker G
Anal Biochem; 2006 Nov; 358(1):51-8. PubMed ID: 16942742
[TBL] [Abstract][Full Text] [Related]
26. Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
Yang ZY; Liu GQ
Pharmazie; 2004 Dec; 59(12):952-6. PubMed ID: 15638085
[TBL] [Abstract][Full Text] [Related]
27. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
28. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
29. GKT136901 protects primary human brain microvascular endothelial cells against methamphetamine-induced blood-brain barrier dysfunction.
Hwang JS; Cha EH; Ha E; Park B; Seo JH
Life Sci; 2020 Sep; 256():117917. PubMed ID: 32525001
[TBL] [Abstract][Full Text] [Related]
30. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
Neuhaus W; Stessl M; Strizsik E; Bennani-Baiti B; Wirth M; Toegel S; Modha M; Winkler J; Gabor F; Viernstein H; Noe CR
Neurosci Lett; 2010 Jan; 469(2):224-8. PubMed ID: 19963040
[TBL] [Abstract][Full Text] [Related]
31. Correlation of the presence of blood-brain barrier tight junctions and expression of zonula occludens protein ZO-1 in vitro: a freeze-fracture and immunofluorescence study.
Gao P; Shivers RR
J Submicrosc Cytol Pathol; 2004 Jan; 36(1):7-15. PubMed ID: 15311669
[TBL] [Abstract][Full Text] [Related]
32. The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism.
Chikhale EG; Burton PS; Borchardt RT
J Pharmacol Exp Ther; 1995 Apr; 273(1):298-303. PubMed ID: 7714780
[TBL] [Abstract][Full Text] [Related]
33. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
Cohen-Kashi Malina K; Cooper I; Teichberg VI
Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
[TBL] [Abstract][Full Text] [Related]
34. Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood-brain barrier.
Camenzind RS; Chip S; Gutmann H; Kapfhammer JP; Nitsch C; Bendfeldt K
Neuroscience; 2010 Sep; 170(1):361-71. PubMed ID: 20603190
[TBL] [Abstract][Full Text] [Related]
35. In vitro evidence of dysregulation of blood-brain barrier function after acute and repeated/long-term exposure to TiO(2) nanoparticles.
Brun E; Carrière M; Mabondzo A
Biomaterials; 2012 Jan; 33(3):886-96. PubMed ID: 22027597
[TBL] [Abstract][Full Text] [Related]
36. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
[TBL] [Abstract][Full Text] [Related]
37. Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R; Lee G; Bendayan M
Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
[TBL] [Abstract][Full Text] [Related]
38. The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions.
Rodriguez PL; Jiang S; Fu Y; Avraham S; Avraham HK
Int J Cancer; 2014 Mar; 134(5):1034-44. PubMed ID: 23934616
[TBL] [Abstract][Full Text] [Related]
39. Novel effects of edaravone on human brain microvascular endothelial cells revealed by a proteomic approach.
Onodera H; Arito M; Sato T; Ito H; Hashimoto T; Tanaka Y; Kurokawa MS; Okamoto K; Suematsu N; Kato T
Brain Res; 2013 Oct; 1534():87-94. PubMed ID: 23958343
[TBL] [Abstract][Full Text] [Related]
40. Assessing blood-brain barrier function using in vitro assays.
Bressler J; Clark K; O'Driscoll C
Methods Mol Biol; 2013; 1066():67-79. PubMed ID: 23955734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
